rs10899970 - LINC00841 - LINC03089
Magnitude 2.2 · 1 study on file
Reported associations
-
Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification - Unknown journal (n.d.) · Unknown authors · PubMed 37770635
ABSTRACT: Coronary artery calcification (CAC), a measure of subclinical atherosclerosis, predicts future symptomatic coronary artery disease (CAD). Identifying genetic risk factors for CAC may point to new therapeutic avenues for prevention. Currently, there are only 4 known risk loci for CAC identified from genome-wide association studies (GWAS) in the general population. Here, we conducted the largest multi-ancestry GWAS meta-analysis of CAC to date, which comprised 26,909 individuals of European ancestry and 8,867 individuals of African ancestry. We identified 11 independent risk loci, of which 8 are novel for CAC and 5 have not been reported for CAD. These novel CAC loci are related to bone mineralization, phosphate catabolism, and hormone metabolic pathways. Several novel loci harbor
Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.
Lifestyle context
Concrete actions anchored to the cited research. We do not prescribe, we describe.
Discuss with your doctor
-
cardiovascular risk stratification Moderate
Genetic variants affecting coronary artery calcification can help identify individuals who may benefit from more intensive cardiovascular risk factor management.
Screening
-
coronary artery calcification screening Moderate
This variant is associated with increased coronary artery calcification, a marker of subclinical atherosclerosis and cardiovascular disease risk.
Discuss with your cardiologist about whether CAC screening (CT scan) is appropriate for your age and risk profile.